Dengue determinants: Necessities and challenges for universal dengue vaccine development

Area of Science:

• * Virology and Immunology
• * Infectious Diseases
• * Vaccine Development

Background:

• * Dengue fever, an Aedes-borne viral illness, poses a significant global health threat, affecting up to a third of the world's population.
• * Current treatments for severe dengue are limited to supportive care, highlighting the urgent need for effective vaccines.
• * Existing dengue vaccine candidates show variable efficacy influenced by serostatus and age, necessitating further research.

Purpose of the Study:

• * To review the multifaceted determinants influencing dengue infection outcomes and vaccine development.
• * To identify key challenges hindering the creation of a universal dengue vaccine.
• * To provide insights for future dengue vaccine design and implementation.

Main Methods:

• * Comprehensive literature review of dengue virus characteristics, host-pathogen interactions, and vaccine strategies.
• * Analysis of factors affecting dengue vaccine efficacy and safety.
• * Integration of immunological and genetic determinants impacting dengue control.

Main Results:

• * Dengue virus exhibits four serotypes, with prior immunity offering only temporary protection against others.
• * Numerous factors, including viral heterogeneity, host genetics, and immunological responses like antibody-dependent enhancement, complicate vaccine development.
• * Current vaccine candidates face limitations in efficacy and broad applicability.

Conclusions:

• * A universal dengue vaccine requires addressing complex viral and host factors.
• * Overcoming challenges such as viral diversity and immune interference is critical for successful vaccine design.
• * Further research into these determinants will guide the development of more effective dengue vaccines.